Intra-articular administration of gelatin hydrogels incorporating rapamycin-micelles reduces the development of experimental osteoarthritis in a murine model.

[1]  J. Pelletier,et al.  Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis , 2014, Annals of the rheumatic diseases.

[2]  Shouan Zhu,et al.  The amelioration of cartilage degeneration by ADAMTS-5 inhibitor delivered in a hyaluronic acid hydrogel. , 2014, Biomaterials.

[3]  G. Klintmalm,et al.  The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence , 2014, Journal of transplantation.

[4]  L. Joosten,et al.  Autophagy activity is up-regulated in adipose tissue of obese individuals and modulates proinflammatory cytokine expression. , 2012, Endocrinology.

[5]  T. Matsushita,et al.  Autophagy modulates osteoarthritis-related gene expression in human chondrocytes. , 2012, Arthritis and rheumatism.

[6]  D. D’Lima,et al.  Mechanical injury suppresses autophagy regulators and pharmacologic activation of autophagy results in chondroprotection. , 2012, Arthritis and rheumatism.

[7]  M. Lotz,et al.  Autophagy activation by rapamycin reduces severity of experimental osteoarthritis , 2011, Annals of the rheumatic diseases.

[8]  Y. Iwamoto,et al.  CCAAT/enhancer binding protein β regulates expression of matrix metalloproteinase-3 in arthritis , 2011, Annals of the rheumatic diseases.

[9]  Siyoung Yang,et al.  Interleukin-6 plays an essential role in hypoxia-inducible factor 2α-induced experimental osteoarthritic cartilage destruction in mice. , 2011, Arthritis and rheumatism.

[10]  José Becerra,et al.  Nanomaterials and hydrogel scaffolds for articular cartilage regeneration. , 2011, Tissue engineering. Part B, Reviews.

[11]  M. Lotz,et al.  Autophagy and cartilage homeostasis mechanisms in joint health, aging and OA , 2011, Nature Reviews Rheumatology.

[12]  J. Tschopp,et al.  Autophagy Controls IL-1β Secretion by Targeting Pro-IL-1β for Degradation , 2011, The Journal of Biological Chemistry.

[13]  Kozo Nakamura,et al.  A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo‐controlled trial , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  D. Klionsky.  The autophagy connection. , 2010, Developmental cell.

[15]  Y. Tabata,et al.  Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[16]  P Tugwell,et al.  OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. , 2010, Osteoarthritis and cartilage.

[17]  F. Navarro-Garcia,et al.  Cell death of chondrocytes is a combination between apoptosis and autophagy during the pathogenesis of Osteoarthritis within an experimental model , 2010, Apoptosis.

[18]  M-P. Hellio Le Graverand-Gastineau.  OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed? , 2009 .

[19]  Marco Pahor,et al.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.

[20]  T. Kubo,et al.  Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee. , 2009, Clinical and experimental rheumatology.

[21]  C. Sanchez,et al.  Bone growth during rapamycin therapy in young rats , 2009, BMC pediatrics.

[22]  Daniel J. Klionsky,et al.  Autophagy fights disease through cellular self-digestion , 2008, Nature.

[23]  Guido Kroemer,et al.  Autophagy in the Pathogenesis of Disease , 2008, Cell.

[24]  K. Fundel,et al.  Activation of interleukin-1 signaling cascades in normal and osteoarthritic articular cartilage. , 2007, The American journal of pathology.

[25]  S. Glasson,et al.  The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. , 2007, Osteoarthritis and cartilage.

[26]  Y. Tabata,et al.  A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I-IIa study. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[27]  J. Jansen,et al.  Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. , 2007, Osteoarthritis and cartilage.

[28]  T. Cawston,et al.  Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. , 2006, Best practice & research. Clinical rheumatology.

[29]  T. Aigner,et al.  Osteoarthritis: pathobiology-targets and ways for therapeutic intervention. , 2006, Advanced drug delivery reviews.

[30]  S. Jimenez,et al.  Osteoarthritis cartilage histopathology: grading and staging. , 2006, Osteoarthritis and cartilage.

[31]  B. Olsen,et al.  Activation of the Discoidin Domain Receptor 2 Induces Expression of Matrix Metalloproteinase 13 Associated with Osteoarthritis in Mice*♦ , 2005, Journal of Biological Chemistry.

[32]  Tibor Vellai,et al.  Genetics: Influence of TOR kinase on lifespan in C. elegans , 2003, Nature.

[33]  M. Sporn,et al.  The triterpenoid CDDO inhibits expression of matrix metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in primary human chondrocytes , 2003, Arthritis research & therapy.

[34]  T. Aigner,et al.  Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. , 2002, Arthritis and rheumatism.

[35]  M. Goldring,et al.  Osteoarthritis and cartilage: The role of cytokines , 2000, Current rheumatology reports.

[36]  K. Choe,et al.  Apoptotic chondrocyte death in human osteoarthritis. , 2000, The Journal of rheumatology.

[37]  F. Blanco,et al.  Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. , 1998, Arthritis and rheumatism.

[38]  J. Reginster,et al.  Effects of exogenous IL-1β, TNFα, IL-6, IL-8 and LIF on cytokine production by human articular chondrocytes , 1996 .

[39]  Stuart L. Schreiber,et al.  A mammalian protein targeted by G1-arresting rapamycin–receptor complex , 1994, Nature.

[40]  K. Otsu,et al.  The role of autophagy in the heart , 2009, Cell Death and Differentiation.

[41]  林田 光正.  CCAAT/enhancer-binding protein beta mediates expression of matrix metalloproteinase-13 in human articular chondrocytes in inflammatory arthritis , 2009 .

[42]  M. Hellio Le Graverand-Gastineau,et al.  OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed? , 2009, Osteoarthritis and cartilage.

[43]  T. Aigner,et al.  Freshly isolated osteoarthritic chondrocytes are catabolically more active than normal chondrocytes, but less responsive to catabolic stimulation with interleukin-1beta. , 2005, Arthritis and rheumatism.